The decision to continue or discontinue tirzepatide should be individualized, weighing the medication's metabolic benefits against the severity and impact of skin symptoms
Patients should contact their healthcare provider if lightheadedness is severe, persistent, or worsening despite self-management strategies
Direct targeting of SLC7A11 includes the use of inhibitors: sulfasalazine (128, 129), erastin (130, 131), imidazole ketone erastin (IKE) (132), sorafenib (133, 134), and HG106 (78)
Expect monitoring
showed that meth treatment increases PKC and protein phosphatase 2 A (PP2A) activity while decreasing tyrosine hydroxylase phosphorylation at serine 40, dopamine levels, and PKA activity in the mouse striatum [99]
What Documentation Do Payers Require